Sangamo Therapeutics, Inc. (SGMO) Social Stream
SANGAMO THERAPEUTICS INC (SGMO) Price Targets From Analysts
Use the tables below to see what analysts covering SANGAMO THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-08 | 9 | $25 | $11 | $17.875 | $0.505 | 3439.6% |
2021-12-14 | 9 | $25 | $9 | $17.5 | $0.505 | 3365.35% |
2022-01-06 | 9 | $25 | $9 | $17.428 | $0.505 | 3351.09% |
2022-02-08 | 8 | $25 | $6 | $16.857 | $0.505 | 3238.02% |
2022-02-25 | 8 | $25 | $6 | $16.571 | $0.505 | 3181.39% |
2022-04-01 | 8 | $25 | $6 | $16.428 | $0.505 | 3153.07% |
2022-04-05 | 7 | $25 | $6 | $15.857 | $0.505 | 3040% |
2022-05-06 | 7 | $25 | $6 | $15 | $0.505 | 2870.3% |
2022-05-09 | 7 | $25 | $6 | $14.833 | $0.505 | 2837.23% |
2022-05-10 | 7 | $25 | $4.4 | $14.566 | $0.505 | 2784.36% |
2022-06-08 | 7 | $25 | $4.4 | $13.066 | $0.505 | 2487.33% |
2022-08-05 | 7 | $25 | $4.4 | $12.233 | $0.505 | 2322.38% |
2022-11-03 | 7 | $25 | $5 | $12 | $0.505 | 2276.24% |
2022-12-16 | 8 | $25 | $4 | $12.857 | $0.505 | 2445.94% |
2023-01-04 | 8 | $25 | $4 | $12.142 | $0.505 | 2304.36% |
2023-02-08 | 8 | $25 | $4 | $11.714 | $0.505 | 2219.6% |
2023-02-23 | 9 | $25 | $4 | $11.875 | $0.505 | 2251.49% |
2023-02-26 | 9 | $25 | $4 | $11.525 | $0.505 | 2182.18% |
2023-02-27 | 9 | $25 | $4.2 | $13.025 | $0.505 | 2479.21% |
2023-02-28 | 9 | $25 | $4.2 | $12.9 | $0.505 | 2454.46% |
2023-03-03 | 9 | $16 | $4.2 | $11.65 | $0.505 | 2206.93% |
2023-04-27 | 9 | $16 | $4.2 | $11.65 | $0.505 | 2206.93% |
2023-04-28 | 9 | $16 | $1.5 | $11.175 | $0.505 | 2112.87% |
2023-05-01 | 9 | $16 | $1.5 | $9.925 | $0.505 | 1865.35% |
2023-07-20 | 10 | $16 | $1.5 | $8.925 | $0.505 | 1667.33% |
2023-08-09 | 10 | $16 | $1.5 | $8.788 | $0.505 | 1640.2% |
2023-08-14 | 10 | $10 | $1.5 | $6.122 | $0.505 | 1112.28% |
2023-08-15 | 10 | $10 | $1.5 | $6.011 | $0.505 | 1090.3% |
2023-10-27 | 10 | $10 | $0.5 | $5.9 | $0.505 | 1068.32% |
2023-11-03 | 9 | $9 | $0.5 | $4.687 | $0.505 | 828.12% |
2023-11-06 | 9 | $8 | $0.5 | $3.071 | $0.505 | 508.12% |
The Trend in the Analyst Price Target
Over the past 22 months, SGMO's average price target has gone down $13.79.
SGMO reports an average of 538.56% for its upside potential over the past 41 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-02-26 | 9 | 25 | 4.0 | 11.525 | 2.655 | 334.09% |
2023-03-03 | 9 | 16 | 4.2 | 11.650 | 2.850 | 308.77% |
2023-05-01 | 9 | 16 | 1.5 | 9.925 | 1.510 | 557.28% |
2023-07-20 | 9 | 16 | 1.5 | 8.925 | 1.425 | 526.32% |
2023-08-14 | 10 | 10 | 1.5 | 6.122 | 1.020 | 500.2% |
SGMO Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2 | 5 | 0 | 3 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 15 months, SGMO's average broker recommendation rating worsened by 0.21.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how SANGAMO THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 3447.65% of that group.
- To contextualize these metrics, consider that out of all US stocks, SANGAMO THERAPEUTICS INC's variance in analysts' estimates is lower than -3206.35% of them.
- In the context of stocks in the mid market cap category, SANGAMO THERAPEUTICS INC's average analyst price target is higher than 499.07% of them.
- SGMO has a greater number of analysts covering the stock than 2026.77% of stocks in the mid market cap category.
Stocks similar to SANGAMO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VCEL, BCRX, and IMCR.
View All Top Stocks by Price Target
Is SGMO a Buy, Hold or Sell? See the POWR Ratings now!